On December 14, 2021, the board of directors (the “Board”) of Avalo Therapeutics, Inc. (the “Company”) appointed Steven J. Boyd, a current non-employee director of the Board, as Chairman of the Board, after unanimously voting to separate the Chief Executive Officer and Chairman roles. Mr. Boyd replaces Michael Cola as Chairman and Mr. Cola will continue to serve on the Board and as Chief Executive Officer of the Company. Dr. Magnus Persson will remain Lead Independent Director of the Board.
Avalo Therapeutics Appoints Steven J. Boyd As Chairman Of Board
On December 14, 2021, the board of directors (the “Board”) of Avalo Therapeutics, Inc. (the “Company”) appointed Steven J. Boyd, a current non-employee director of the Board, as Chairman of the
